Novel Treatments in Refractory Recurrent Pericarditis [PDF]
PharmaceuticalsRefractory recurrent pericarditis is a troublesome condition that severely impairs the quality of life of affected patients and significantly increases healthcare spending.
Emilia Lazarou +7 more
doaj +5 more sources
Comparative Efficacy and Safety of Colchicine and Anti–Interleukin‐1 Agents in Recurrent Pericarditis: A Pairwise and Network Meta‐Analysis of Randomized Controlled Trials [PDF]
Journal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseBackground The management of recurrent pericarditis includes colchicine and anti–interleukin‐1 agents, given the limited efficacy and adverse effects of NSAIDs and corticosteroids.
Muhammad Ehsan +8 more
doaj +3 more sources
Interleukin-1 Blockers: A Paradigm Shift in the Treatment of Recurrent Pericarditis [PDF]
LifeRecurrent pericarditis is a problematic clinical condition that impairs the quality of life of the affected patients due to the need for repeated hospital admissions, emergency department visits, and complications from medications, especially ...
Emilia Lazarou +9 more
doaj +3 more sources
A Rare Cause of Recurrent Pericarditis. [PDF]
CureusRecurrent pericarditis poses a significant challenge to clinicians, particularly when patients are unresponsive or intolerant to conventional treatments. Accurate diagnosis of recurrent pericarditis, potentially facilitated by collaboration with other medical specialties, is crucial for ensuring timely and appropriate treatment of symptoms and ...
Aletras G +4 more
europepmc +4 more sources
IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis. [PDF]
JAMA Netw OpenThis cohort study investigates the prevalence and role of autoantibodies targeting the endogenous interleukin 1 (IL-1) receptor antagonist in patients with recurrent pericarditis with an inflammatory phenotype.
Wu MA +14 more
europepmc +2 more sources
Current Drug Treatment for Acute and Recurrent Pericarditis. [PDF]
DrugsPericarditis is the most frequent pericardial disease and presents with a relatively benign course when treated according to guideline-directed therapies at first presentation.
Bonaventura A +3 more
europepmc +2 more sources
Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report. [PDF]
Eur Heart J Case RepBackground Recurrent pericarditis is the most common and troublesome complication of pericarditis and can be particularly challenging when it becomes refractory to conventional therapies, often resulting in a prolonged disease course. Interleukin-1 (IL-1)
Collini V +4 more
europepmc +2 more sources
Incidence and Factors Associated With Recurrent Pericarditis in Lupus.
JAMA Netw OpenThis cohort study investigates the incidence of recurrent pericarditis among patients with a history of systemic lupus erythematosus (SLE) and factors associated with recurrence.
Kim YJ +7 more
europepmc +2 more sources
Interleukin-1 Inhibitors for Management of Recurrent Pericarditis After Thoracic Organ Transplantation. [PDF]
JACC Case RepThere is a growing body of evidence supporting the safety and utility of interleukin-1 inhibitors for treatment of recurrent pericarditis. This therapy has not been investigated specifically as related to postpericardiotomy syndrome or after thoracic ...
Rajput B, Singh A, Garshick MS.
europepmc +2 more sources
US Database Study of Clinical Burden and Unmet Need in Recurrent Pericarditis
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Patients with recurrent pericarditis (RP) may develop complications, multiple recurrences, or inadequate treatment response. This study aimed to characterize disease burden and unmet needs in RP.
Allan Klein +7 more
doaj +3 more sources